LOJACONO, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 7.603
EU - Europa 4.258
AS - Asia 3.657
SA - Sud America 652
AF - Africa 94
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 16.287
Nazione #
US - Stati Uniti d'America 7.495
CN - Cina 1.343
SG - Singapore 1.249
UA - Ucraina 812
DE - Germania 763
PL - Polonia 681
IT - Italia 568
BR - Brasile 548
HK - Hong Kong 412
FR - Francia 331
GB - Regno Unito 256
FI - Finlandia 249
RU - Federazione Russa 220
VN - Vietnam 181
TR - Turchia 135
IE - Irlanda 129
IN - India 109
EE - Estonia 93
MX - Messico 55
BD - Bangladesh 52
SE - Svezia 37
ZA - Sudafrica 36
CA - Canada 34
AR - Argentina 31
IQ - Iraq 25
BE - Belgio 21
EC - Ecuador 20
JP - Giappone 19
NG - Nigeria 19
NL - Olanda 19
ID - Indonesia 18
SA - Arabia Saudita 18
AU - Australia 14
PK - Pakistan 14
UZ - Uzbekistan 14
AT - Austria 13
ES - Italia 13
CO - Colombia 12
CL - Cile 10
EG - Egitto 9
EU - Europa 8
UY - Uruguay 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
TH - Thailandia 7
CZ - Repubblica Ceca 6
IR - Iran 6
KZ - Kazakistan 6
JM - Giamaica 5
JO - Giordania 5
MU - Mauritius 5
NP - Nepal 5
PE - Perù 5
PY - Paraguay 5
BG - Bulgaria 4
BH - Bahrain 4
HR - Croazia 4
LT - Lituania 4
MA - Marocco 4
RS - Serbia 4
AL - Albania 3
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
GR - Grecia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
OM - Oman 3
PH - Filippine 3
PT - Portogallo 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
DK - Danimarca 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
KE - Kenya 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MY - Malesia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
Totale 16.276
Città #
Fairfield 815
Woodbridge 710
Singapore 691
Warsaw 678
Ashburn 603
Jacksonville 576
Houston 441
Hong Kong 406
Ann Arbor 344
Chandler 323
Cambridge 319
Seattle 301
Wilmington 284
Beijing 278
The Dalles 247
Princeton 244
San Jose 240
Nanjing 220
Los Angeles 196
New York 188
Helsinki 132
Buffalo 131
Dublin 129
Istanbul 112
Lauterbourg 107
Tallinn 93
Nanchang 83
Des Moines 67
Dearborn 66
Milan 63
Ho Chi Minh City 61
Moscow 60
São Paulo 60
Shenyang 56
Lancaster 53
Munich 53
Hebei 47
San Diego 46
Changsha 45
Shanghai 42
Rome 41
Verona 37
Jinan 35
Tianjin 35
Hanoi 34
Brescia 32
San Francisco 32
Dallas 29
Jiaxing 29
Santa Clara 28
Chennai 27
Nürnberg 26
Chicago 25
Hangzhou 24
Redondo Beach 23
London 22
Zhengzhou 22
Guangzhou 21
Brussels 20
Genova 20
Abuja 19
Denver 19
Tokyo 19
Council Bluffs 18
Dong Ket 18
Johannesburg 18
Phoenix 18
Orem 17
Taizhou 17
Rio de Janeiro 16
Belo Horizonte 14
Boardman 14
Ningbo 14
Brasília 13
Mexico City 13
Mumbai 13
Naples 13
Poplar 13
Tashkent 13
Turku 13
Dhaka 12
Monterrey 12
Amsterdam 11
Baghdad 11
Brooklyn 11
Guayaquil 11
Kunming 11
Lanzhou 11
Nuremberg 11
Toronto 11
Charlotte 10
Falkenstein 10
Manchester 10
Montreal 10
Porto Alegre 10
Riyadh 10
Auburn Hills 9
Boston 9
Florence 9
Ribeirão Preto 9
Totale 10.692
Nome #
Bambini pretermine: nati per vivere 359
Parto e puerperio: i vissuti delle donne in un'ottica di ricerca multidisciplinare. 327
Variabili psicologiche materne e andamento del parto: rilevazione in un campione di donne italiane alla prima esperienza di parto. 325
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 316
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 305
Percorso nascita: un progetto di ricerca multidisciplinare. 287
Long-term outcome of children of rheumatic disease patients 231
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 202
L’approccio multidisciplinare alla nascita: parto, puerperio, visti dalle donne. 197
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 188
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 186
Cerebroplacental ratio before induction of labour in normally grown fetuses at term and intrapartum fetal compromise 185
Dinoprostone per l'induzione del travaglio di parto in pazienti con Bishop score favorevole: confronto tra gel vaginale e pessario vaginale a rilascio prolungato 179
Children born to SLE and APS mothers 175
L’approccio multidisciplinare alla nascita: parto e puerperio visti dalle donne. 173
A randomized controlled trial of 24-hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score 166
Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study 163
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 160
Uterine artery velocimetry in patients with gestational hypertension 159
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 159
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 159
Prophylactic oral nifedipine to reduce preterm delivery: a randomized controlled trial in women at high risk 158
Labor course and delivery in epidural analgesia: a case-control study 156
Pregnancy complications of the antiphospholipid syndrome 155
Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies 154
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 152
Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. 149
Impact of in utero environment on the offspring of lupus patients 147
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome 147
Neuropsychological development of children born to patients with systemic lupus erythematosus 145
Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. 145
Insulinoma Identified in Puerperium: Association with Pregnancy and Literature Review 145
Autoimmunity and pregnancy: autoantibodies and pregnancy in rheumatic diseases 144
PROSPECTIVELY FOLLOWED PREGNANCIES IN PATIENTS WITH SYSTEMIC VASCULITIS: STILL MANY PROBLEMS ON BOTH FOETAL AND MATERNAL SIDE 143
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 142
Offspring of Women with Systemic Autoimmune diseases: fetal and neonatal complications and inheritance of autoimmune diseases. 142
Predictors of maternal and fetal complications in SLE patients: a prospective study 139
Cerebral ultrasound abnormalities in infants born to mothers with autoimmune disease 138
Neonatal outcome in patients with rheumatic disease 137
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 137
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 137
Follow up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation 136
Idiopathic eosinophilic pneumonia and pregnancy: report of a case. 136
Neonatal effects of maternal antiphospholipid syndrome. 135
Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study 135
Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I 135
Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and in preeclampsia 133
European registry of babies born to mothers with antiphospholipid syndrome. 133
Atypical presentation and imaging features of postpartum posterior reversible encephalopathy syndrome 133
The Efficacy and Safety of Cyclosporin A in Pregnant Patients with Systemic Autoimmune Diseases 132
Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents 131
Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. 131
Infertility in women with systemic autoimmune diseases 131
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome 130
Pregnancy and neonatal outcome in primary antiphospholipid syndrome. 128
Neuropsychological development of children born to patients with antiphospholipid syndrome. 128
The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women. 125
Assistenza e sorveglianza nel travaglio di parto a basso rischio 124
Autoantibodies and prediction of reproductive failure. 123
Neonates born from mothers with autoimmune disorders 122
Anti-{beta}2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile? 121
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 121
Complement Activation and Pregnancy Failure. 120
Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction 119
Transabdominal uterine arteries Doppler between 11-14 weeks of gestation for prediction of outcome in high risk pregnancies 119
Variabili psicologiche materne e andamento clinico del parto 117
Is it possible to differentiate "Natural" Antiphospholipid antibodies from "Thrombophilic" ones? Analysis of the fine specificity against the domains of Beta2glycoprotein I 116
Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome 114
Anti beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome 114
Correlation between fetal Doppler indices and neonatal acid–base status at birth in healthy appropriate for gestational age term fetuses 114
Autoimmune diseases and pregnancy 114
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 113
Pregnancy in systemic sclerosis: a prospective study 113
IgG anti-B2glycoprotein I antibodies form one-year-old children born to mothers with systemic autoimmune diseases preferentially target domain 4/5 112
Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert 111
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases 111
External cephalic version for breech presentation at term: an effective procedure to reduce the caesarean section rate 109
THE FINE SPECIFICITY OF ANTI-BETA2GLYCOPROTEIN I ANTIBODIES IN SYSTEMIC AUTOIMMUNE DISEASES IS PREFERENTIALLY DIRECTED AGAINST DOMAIN 1 109
Esperienza personale nel trattamento delle emorragie gastroduodenali mediante l'associazione di somatostatina e ranitidina 107
ANTICORPI ANTIFOSFOLIPIDI: E' POSSIBILE DISTINGUERE GLI ANTICORPI "INNOCENTI" DA QUELLI "TROMBOFILICI"? ANALISI DELLA FINE SPECIFICITA' DIRETTA VERSO I DOMINI DELLA BETA2GLICOPROTEINA I 107
LA FINE SPECIFICITA' DEGLI ANTICORPI ANTI-BETA2GLICOPROTEINA I NELLE MALATTIE AUTOIMMUNI SISTEMICHE E' PREVALENTEMENTE DIRETTA ERSO IL DOMINIO 1 107
Finespecificity of anti-B2glycoprotein I antibodies in sysemic autoimmune diseasesis mostly directed against domain 1 107
Outcome of infants from mothers with anti-SSA/Ro antibodies. 106
Antiphospholipid and anti beta 2 glycoprotein I antibodies in patients with obstetrical complications 105
Systemic lupus erythematosus and pregnancy: a prospective study. 105
Gestational success in patients at risk of preterm labor with presence of ureaplasma urealyticum in cervico-vaginal secretions 103
LONG TERM OUTCOME IN CHILDREN BORN TO MOTHERS WITH SYSTEMIC LUPUS ERYTEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME 103
Thrombophilia is a risk factor for severe preeclampsia and its recurrence 101
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study. 101
Obstetric manifestation of the Antiphospholipid Syndrome 100
ONE-YEAR-OLD CHILDREN BORN TO MOTHERS WITH SYSTEMIC AUTOIMMUNE DISEASES MAY DEVELOP ANTI-BETA2GPI IGG ANTIBODIES THAT PREFERENTIALLY TARGET DOMAIN 4/5 100
Novel aspects of Sjögren’s syndrome in 2012 100
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 100
Reproductive Issues and Pregnancy Implications in Systemic Sclerosis. 98
Contraception in adolescents with systemic lupus erythematosus 97
One-year-old children born to mothers with systemic autoimmune diseases may develop anti-beta2GPI IGg antibodies that preferentially target domain 4/5 97
Clinical followup and screening for autoimmune disorders in patients with previous severe early onset preeclampsia 97
Streptococcus group B and pregnancy: the therapeutic role of topical intravaginal clindamycin 96
PROPOSTA DI UNA TECNOLOGIA OSTETRICA: IL PIANO DI ASSISTENZA OSTETRICA NELLA SORVEGLIANZA DEL BENESSERE MATERNO/FETALE INTRAPARTUM 95
SICUREZZA DEI FARMACI BIOLOGICI ANTI-TNF IN GRAVIDANZA 95
Totale 14.288
Categoria #
all - tutte 70.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021420 0 0 0 0 0 0 0 0 0 156 199 65
2021/2022949 39 169 18 49 13 50 38 67 41 119 93 253
2022/20231.017 138 7 26 78 104 261 4 105 173 5 42 74
2023/2024859 75 27 50 71 36 158 33 37 217 15 2 138
2024/20252.102 9 26 14 342 213 198 177 85 199 134 431 274
2025/20263.783 377 596 397 577 357 262 615 125 228 249 0 0
Totale 16.512